AlgoTx develops novel solutions for complex pain. Our lead program, ATX01, targets highly prevalent Chemotherapy-Induced Peripheral Neuropathy and the orphan disease erythromelalgia.
Location: France, Ile-de-France, Suresnes
Member count: 11-50
Total raised: $21.253172M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 31.03.2021 | Omnes Capi... | omnescapit... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 16.03.2023 | Series B | $21.253172... | - | vcbay.news... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 16.03.2023 | France-bas... | Suresnes, a France-based biote... | - | - | vcbay.news... |
| 15.03.2023 | AlgoTx Rai... | AlgoTx, a Suresnes, France-bas... | France | - | finsmes.co... |